Related Experiment Videos
Osteopontin is a ligand for the alpha4beta1 integrin
K J Bayless1, G A Meininger, J M Scholtz
1Microcirculation Research Institute, Texas A & M University Health Science Center, Texas A & M University, College Station, TX 77843-1114, USA.
Journal of Cell Science
|June 4, 1998
Summary
Osteopontin promotes leukocyte adhesion via the alpha4beta1 integrin, a newly identified receptor. This interaction, crucial in cardiovascular injury, involves a binding site in osteopontin's N-terminal fragment.
Area of Science:
- Cardiovascular Biology
- Immunology
- Cell Adhesion
Background:
- Osteopontin expression increases at cardiovascular injury sites.
- Osteopontin is hypothesized to aid vascular wall remodeling by providing an adhesive matrix.
- Monocytes and macrophages synthesize osteopontin at injury sites.
Purpose of the Study:
- To investigate osteopontin's role in leukocyte adhesion.
- To identify the specific integrin receptor involved in osteopontin-mediated leukocyte adhesion.
Main Methods:
- Osteopontin-mediated leukocyte adhesion assays using HL-60 and Ramos cells.
- Inhibition studies using anti-integrin antibodies and specific peptides (LDV/LEV).
- Affinity chromatography and immunoprecipitation to identify the binding integrin.
Main Results:
- Osteopontin promoted leukocyte adhesion, dependent on leukocyte activation.
- Adhesion was specifically inhibited by antibodies targeting the alpha4beta1 integrin.
- A leucine-aspartate-valine (LDV) peptide, but not LEV, blocked binding.
- The alpha4beta1 integrin was identified as the specific receptor for osteopontin.
- A 30 kDa N-terminal fragment of osteopontin mediated similar alpha4beta1-dependent adhesion.
Conclusions:
- Osteopontin functions as an adhesive ligand for leukocytes through the alpha4beta1 integrin.
- A functional alpha4beta1-binding site is located within the N-terminal thrombin fragment of osteopontin.
- These findings reveal a novel mechanism of leukocyte recruitment in vascular injury contexts.